Real World Experience

Russo Partners has a history. From the evolution of biotech to the launch of pharmaceutical marketing 2.0, we have been there every step of the way.

We’re not all talk. PR isn’t just about getting a message out. It’s getting the right message to the right people at the right time. At Russo Partners, we do just that – and so much more.

At Russo Partners, communications counselors with PhDs, MDs, JDs and MBAs roll up their sleeves to implement integrated programs for biopharma, medtech, diagnostics, healthcare IT and healthcare services companies worldwide.

Since our founding as Noonan/Russo more than 25 years ago, we’ve been on a first-name basis with the people you need to be talking to. Which means you should be talking to us.

Latest News

 

Dec
8

Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2016 San Antonio Breast Cancer Symposium

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that interim results from a Phase II clinical trialREAD MORE…

Dec
5

Corbus Pharmaceuticals Announces NASDAQ Closing Bell Ceremony

NORWOOD, MA — (Marketwired) — 12/05/16 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stageREAD MORE…

Dec
1

Cyclacel’s Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential in Esophageal Cancer and Acute Leukemia

BERKELEY HEIGHTS, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceuticalREAD MORE…

Twitter Stream